Ampelopsin Suppresses Stem Cell Properties Accompanied by Attenuation of Oxidative Phosphorylation in Chemo- and Radio-Resistant MDA-MB-231 Breast Cancer Cells

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phytochemicals as Potential Anticancer Drugs: Time to Ponder Nature’s Bounty

(2020) Mohammad Arif Ashraf   Biomed Research International

Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin

(2020) Yen Thi-Kim Nguyen et al.   Cancers

Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism

(2020) Joshua Silva et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis

(2020) Huan Gao et al.   BIOMEDICINE & PHARMACOTHERAPY

Increased Oxidative Phosphorylation Is Required for Stemness Maintenance in Liver Cancer Stem Cells from Hepatocellular Carcinoma Cell Line HCCLM3 Cells

(2020) Ge Liu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling

(2020) Ngoc Bao To et al.   Nutrients

Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

(2020) Sandra Valle et al.   Nature Communications

Targeting the Wnt/β-catenin signaling pathway in cancer

(2020) Ya Zhang et al.   Journal of Hematology & Oncology

Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer

(2020) Aishat Motolani et al.   Biomolecules

Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2

(2019) So Koh et al.   Nutrients

Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase

(2019) Liming Huang et al.   Oncology Letters

AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression

(2019) Hong-Chun Xiang et al.   Journal of Neuroinflammation

Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways

(2019) Zhenjiang Zhao et al.   INFLAMMOPHARMACOLOGY

NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond

(2019) Daria Capece et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability

(2019) Dan Liu et al.   TRENDS IN FOOD SCIENCE & TECHNOLOGY

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer

(2019) Park et al.   Cancers

Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway

(2019) Zhigang Guo et al.   BIOMEDICINE & PHARMACOTHERAPY

Oxidative phosphorylation as a potential therapeutic target for cancer therapy

(2019) Valentina Sica et al.   INTERNATIONAL JOURNAL OF CANCER

Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases

(2019) Haihui Tong et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide

(2018) Allison Knickle et al.   FOOD AND CHEMICAL TOXICOLOGY

Quercetin Suppresses CYR61-Mediated Multidrug Resistance in Human Gastric Adenocarcinoma AGS Cells

(2018) Ho Hyun et al.   MOLECULES

Cancer Stem Cell Metabolism and Potential Therapeutic Targets

(2018) Vusala Snyder et al.   Frontiers in Oncology

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin

(2018) Jingyao Zhang et al.   Frontiers in Pharmacology

Breast cancer stem cells: Biology and therapeutic implications

(2018) Ramesh Butti et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism

(2017) Balaraman Kalyanaraman   Redox Biology

Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin

(2017) Yingqi Xu et al.   Scientific Reports

Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models

(2016) Seung-Hee Kim et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells

(2016) Lotfi M. Bassa et al.   PHYTOMEDICINE

The Regulation of NF-κB Subunits by Phosphorylation

(2016) Frank Christian et al.   Cells

The NF-κB Pathway and Cancer Stem Cells

(2016) Amanda Rinkenbaugh et al.   Cells

Epithelial-Mesenchymal Plasticity of Breast Cancer Stem Cells: Implications for Metastasis and Therapeutic Resistance

(2015) Ming Luo et al.   CURRENT PHARMACEUTICAL DESIGN

Targeting Cancer Stem Cells in Breast Cancer: Potential Anticancer Properties of 6-Shogaol and Pterostilbene

(2015) Chi-Hao Wu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway

(2015) Shreyasi Palit et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres

(2015) Ean-Jeong Seo et al.   PHYTOMEDICINE

Targeting AMPK for cancer prevention and treatment

(2015) Weidong Li et al.   Oncotarget

Metabolic differences in breast cancer stem cells and differentiated progeny

(2014) Erina Vlashi et al.   BREAST CANCER RESEARCH AND TREATMENT

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

(2014) Wei Wang et al.   CURRENT MEDICINAL CHEMISTRY

Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways

(2014) Juan Xia et al.   FOOD AND CHEMICAL TOXICOLOGY

Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line

(2013) Ling Wang et al.   Cancer Cell International

PPM1A is a RelA phosphatase with tumor suppressor-like activity

(2013) X Lu et al.   ONCOGENE

Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest

(2013) L Lundholm et al.   Cell Death & Disease

Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells

(2012) Li-xia Dong et al.   ACTA PHARMACOLOGICA SINICA

Phytochemicals as a potential source for TNF-α inhibitors

(2012) Muzamal Iqbal et al.   PHYTOCHEMISTRY REVIEWS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration

(2011) Claudio Mauro et al.   NATURE CELL BIOLOGY

Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion

(2011) F Yu et al.   ONCOGENE

TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion

(2010) Y Wu et al.   BRITISH JOURNAL OF CANCER

Cancer Stem Cells and Self-renewal

(2010) C. A. O'Brien et al.   CLINICAL CANCER RESEARCH

Hovenia dulcis– An Asian Traditional Herb

(2010) Tae Hyun et al.   PLANTA MEDICA

Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells

(2009) Su-Yu Chien et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Her2 activates NF-κB and induces invasion through the canonical pathway involving IKKα

(2009) E C Merkhofer et al.   ONCOGENE